Skip to main content

UBS Group AG

Position in BCYC — Bicycle Therapeutics PLC

CIK 1610520 ZURICH, V8

Position in BCYC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$65,546
-$83,671 QoQ
Shares Held
15,459
-51.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 103 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 69% Shared 0% None 31%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. BCYC ranks #382 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCYC

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,546 15,459
2026-03-31 $149,217 32,159
2025-12-31 $181,785 25,676
2025-09-30 $88,026 11,373
2025-06-30 $231,955 33,375
2025-03-31 $617,239 72,702
2024-12-31 $1,853,054 132,361
2024-09-30 $273,053 12,066
2024-06-30 $322,523 15,935
2024-03-31 $248,551 9,982
2023-12-31 $201,591 11,150
2023-09-30 $227,117 11,305
2023-06-30 $321,858 12,612
2023-03-31 $295,482 13,892
2022-12-31 $383,082 12,942
2022-09-30 $662,327 28,475
2022-06-30 $217,569 12,966
2022-03-31 $389,829 8,884
2021-12-31 $54,296 892
2021-09-30 $35,185 846
2021-06-30 $52,067 1,715
2021-03-31 $10,514 352
2020-12-31 $4,200 234
2020-09-30 $9,429 495
2020-06-30 $35,965 2,285